Blog

Gamida Cell Ltd.

Gamida Cell Reports StemEx® Phase II/III Study Safety and Efficacy Data
Jerusalem, Israel, — Gamida Cell announced today additional analyses for the Phase II/III, multi-center, multi-national, historical cohort-controlled study to evaluate efficacy and safety of StemEx® as an alternative transplantation treatment for patients with high risk leukemia and lymphoma. Twenty-five bone marrow transplant centers worldwide treating

NanoPass Technologies Ltd.

IDRI and Medicago to present data at the World Vaccine Congress Presentation of Positive Interim Phase I Clinical Trial results for an H5N1 Vaccine with GLA Adjuvant
SEATTLE, WA, and QUEBEC CITY, QC, April 9, 2013 – IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in

Argo Medical Technologies Ltd.

President Obama Views Demonstration of ReWalk Exoskeleton Technology During Visit to Israel
ARGO Medical Technologies’ ReWalk exoskeleton was one of the cutting-edge Israeli inventions demonstrated to President Barack Obama in Israel during his visit to a session hosted by Technion-Israel Institute of Technology. ReWalk inventor Dr. Amit Goffer an alumni of the Technion is a quadriplegic

Gamida Cell Ltd.

Gamida Cell’s StemEx® Achieves Primary Endpoint in Phase II/III Clinical Study
Jerusalem, Israel – Gamida Cell announced today that its flagship product, StemEx, reached its primary endpoint of improving overall survival in a Phase II/III study which compared the use of StemEx as part of a transplantation regimen to historical controls in the treatment of patients

Argo Medical Technologies Ltd.

ARGO Medical Technologies Unveils Advancement of its Exoskeleton Technology with Launch of ReWalk Rehabilitation 2.0
BERLIN, Jan 29, 2013 (BUSINESS WIRE) — ARGO Medical Technologies has unveiled the newest generation of its ReWalk Rehabilitation exoskeleton that enables individuals with spinal cord injuries the ability to walk again. The 2.0 system is designed to make it easier

HomeSkinovations Ltd.

Silk’n Partners with Bed Bath & Beyond Silk’n Flash&Go Now Available at All Bed Bath & Beyond Locations in North America
NEW YORK, Jan. 7, 2013 /PRNewswire via COMTEX/ — Bed Bath & Beyond–the go-to resource for home and beauty–recently added the Silk’n Flash&Go all-over permanent hair removal device to all retail doors in the U.S.

NanoPass Technologies Ltd.

NanoPass Technologies Grants a Commercial License to Janssen Pharmaceuticals, Inc., for use of its MicronJet Device
NanoPass Technologies Ltd. (“NanoPass”), a pioneer in intradermal delivery solutions for vaccines, announced today that it has entered into a license agreement for MicronJet®, its microneedle delivery device, with Janssen Pharmaceuticals, Inc. (JPI) for multiple vaccine fields.The license agreement will

Gamida Cell Ltd.

First Pediatric Sickle Cell Disease Patient Receives NiCord® Stem Cell Transplantation in Gamida Cell Pilot Study at Duke University
erusalem, Israel, November 12, 2012 — Gamida Cell Ltd., a world leader in stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine, announced today that the first patient, enrolled in its

Argo Medical Technologies Ltd.

ARGO Medical Technologies Announces European Commercial Launch of the ReWalk Exoskeleton for Personal Use ARGO executives and several current users showcase the availability of the ReWalk personal system during REHACARE in Dusseldorf, Germany
DUSSELDORF, Germany, Oct 11, 2012 (BUSINESS WIRE) — Exoskeleton technology leader, ARGO Medical Technologies, today announced that its ReWalk is now commercially available

Argo Medical Technologies Ltd.

Governor Patrick Joins Israeli-Founded ARGO Medical Technologies to Announce Selection of Massachusetts as U.S. Headquarters
BOSTON–(BUSINESS WIRE)–Governor Deval Patrick joined the Massachusetts Life Sciences Center and ARGO Medical Technologies at the AdvaMed 2012 conference in Boston today to announce that Israeli-founded exoskeleton technology leader, ARGO, has selected Massachusetts as its U.S. headquarters.
 “Massachusetts is a global leader